journal article·2019-12-04Open access

Labour analgesia; Molecular pathway and the role of nanocarriers: a systematic review

Leila Kafshdooz, Houman Kahroba, Tayebeh Kafshdooz, Roghayeh Sheervalilou, Hojjat Pourfathi

Abstract

Labour is considered to be one of the most painful procedures in human experience. The most effective technique for pain relief during labour is neuraxial labour analgesia which provides analgesia without maternal or fetal sedation. Genetic predisposition may be of importance for pain perception and women experience varying degrees of pain in labour. Genetic variations in opioid receptor (OPR) genes may influence the response to epidural opioid analgesia during labour. The single-nucleotide polymorphism, A118G of the mu opioid receptor gene (oprm1), has been associated with altered pain perception. Targeted drug delivery reduces toxic side effects. Liposomes, nano-particles, nanofibres hydrogel, have been suggested to deliver anaesthetic drugs.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Pain Management and Opioid Use · Anesthesia and Pain Management · Pediatric Pain Management Techniques

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Womens Reproductive Health Research Center, Tabriz University of Medical Sciences,

Molecular Medicine Research Center, Tabriz University of Medical Sciences

Department of Molecular Medicine, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences

Department of Anesthesiology, Faculty of Medicine, Tabriz University of Medical Sciences

References (71)

Show source-provided references
1. 10.1007/s40140-013-0029-210.1007/s40140-013-0029-2 ↗
2. 10.1001/archinte.163.20.243310.1001/archinte.163.20.2433 ↗
3. 10.1213/ANE.0b013e3182713b2610.1213/ANE.0b013e3182713b26 ↗
4. 10.1016/j.ijoa.2009.05.01310.1016/j.ijoa.2009.05.013 ↗
5. 10.1038/nrd259510.1038/nrd2595 ↗
6. 10.1016/j.tig.2007.09.00410.1016/j.tig.2007.09.004 ↗
7. 10.1080/j.0001-6349.2004.0302.x10.1080/j.0001-6349.2004.0302.x ↗
8. 10.1001/jama.1943.0284044002000610.1001/jama.1943.02840440020006 ↗
9. 10.1097/00000542-200509000-0003010.1097/00000542-200509000-00030 ↗
10. 10.1067/mob.2001.11797010.1067/mob.2001.117970 ↗
11. 10.1213/ANE.0b013e31827e4e2910.1213/ANE.0b013e31827e4e29 ↗
12. 10.1016/j.bjane.2012.06.00710.1016/j.bjane.2012.06.007 ↗
13. 10.1111/j.1365-2044.2010.06616.x10.1111/j.1365-2044.2010.06616.x ↗
14. 10.12688/f1000research.11130.110.12688/f1000research.11130.1 ↗
15. 10.3390/ijms1908216410.3390/ijms19082164 ↗
16. 10.1111/j.1523-536X.1990.tb00004.x10.1111/j.1523-536X.1990.tb00004.x ↗
17. 10.1177/20494637080020020510.1177/204946370800200205 ↗
18. 10.1016/0028-2243(95)02058-Z10.1016/0028-2243(95)02058-Z ↗
19. 10.1016/0002-9378(78)90498-210.1016/0002-9378(78)90498-2 ↗
20. 10.2165/00148581-200305090-0000410.2165/00148581-200305090-00004 ↗
21. Ghelardini C, Mannelli LDC, Bianchi E. The pharmacological basis of opioids. Clin Cases Miner Bone Metab. 2015;12:219.
22. 10.1097/ALN.0b013e318238bba610.1097/ALN.0b013e318238bba6 ↗
23. 10.1056/NEJMra02541110.1056/NEJMra025411 ↗
24. 10.1007/978-3-319-59312-8_610.1007/978-3-319-59312-8_6 ↗
25. 10.1089/jpm.2009.005110.1089/jpm.2009.0051 ↗
26. 10.1097/ACO.0b013e328136c1d110.1097/ACO.0b013e328136c1d1 ↗
27. 10.1016/j.cnc.2017.08.00710.1016/j.cnc.2017.08.007 ↗
28. 10.1080/21691401.2018.145493110.1080/21691401.2018.1454931 ↗
29. 10.1016/j.biopha.2016.11.13710.1016/j.biopha.2016.11.137 ↗
30. 10.2174/18722111078995722810.2174/187221110789957228 ↗
31. 10.2217/nnm.15.2310.2217/nnm.15.23 ↗
32. 10.2217/nnm.13.4210.2217/nnm.13.42 ↗
33. 10.1517/17425247.3.4.46310.1517/17425247.3.4.463 ↗
34. 10.1200/JCO.1998.16.10.323810.1200/JCO.1998.16.10.3238 ↗
35. 10.1515/prilozi-2016-001910.1515/prilozi-2016-0019 ↗
36. 10.1111/fcp.1212810.1111/fcp.12128 ↗
37. 10.1111/bcpt.1275710.1111/bcpt.12757 ↗
38. 10.1097/01.j.pain.0000460319.87643.1110.1097/01.j.pain.0000460319.87643.11 ↗
39. 10.1111/papr.1234310.1111/papr.12343 ↗
40. 10.1016/S0031-6997(25)06784-510.1016/S0031-6997(25)06784-5 ↗
41. 10.1016/j.drugalcdep.2011.10.02510.1016/j.drugalcdep.2011.10.025 ↗
42. 10.1517/14622416.2.3.17710.1517/14622416.2.3.177 ↗
43. 10.2217/pgs.11.9610.2217/pgs.11.96 ↗
44. 10.1111/j.1471-4159.2009.06472.x10.1111/j.1471-4159.2009.06472.x ↗
45. 10.2217/pgs.15.15710.2217/pgs.15.157 ↗
46. 10.1016/j.clp.2013.05.01410.1016/j.clp.2013.05.014 ↗
47. 10.1002/humu.902610.1002/humu.9026 ↗
48. 10.1056/NEJMct090925410.1056/NEJMct0909254 ↗
49. 10.1111/j.1369-1600.2011.00422.x10.1111/j.1369-1600.2011.00422.x ↗
50. 10.1089/gtmb.2013.028210.1089/gtmb.2013.0282 ↗
51. Zhang S, Li S, Tan X. Human µ-opioid receptor A118G polymorphism affects epidural patient-controlled analgesia with fentanyl. Nan Fang yi ke da Xue Xue Bao = J Southern Med Univ. 2013;33:309–311.
52. 10.1073/pnas.95.16.960810.1073/pnas.95.16.9608 ↗
53. 10.1186/1756-6606-6-810.1186/1756-6606-6-8 ↗
54. 10.1177/193371911243897010.1177/1933719112438970 ↗
55. 10.1016/j.pain.2008.02.02310.1016/j.pain.2008.02.023 ↗
56. 10.1097/00041444-200309000-0000610.1097/00041444-200309000-00006 ↗
57. 10.1016/j.ijoa.2009.09.00510.1016/j.ijoa.2009.09.005 ↗
58. 10.1016/j.ijoa.2011.10.00110.1016/j.ijoa.2011.10.001 ↗
59. 10.1186/1744-8069-6-4110.1186/1744-8069-6-41 ↗
60. 10.1038/nm149010.1038/nm1490 ↗
61. 10.1016/S0006-8993(00)03161-910.1016/S0006-8993(00)03161-9 ↗
62. 10.1016/S0891-5849(03)00172-210.1016/S0891-5849(03)00172-2 ↗
63. 10.1007/s00439-004-1239-y10.1007/s00439-004-1239-y ↗
64. 10.1097/00008571-199606000-0000710.1097/00008571-199606000-00007 ↗
65. 10.1016/j.neuroimage.2016.02.00610.1016/j.neuroimage.2016.02.006 ↗
66. 10.1089/dna.1991.10.18110.1089/dna.1991.10.181 ↗
67. 10.1126/science.107854610.1126/science.1078546 ↗
68. 10.1128/MCB.22.22.7942-7952.200210.1128/MCB.22.22.7942-7952.2002 ↗
69. 10.1254/jphs.12159FP10.1254/jphs.12159FP ↗
70. Feng S, Li N, Xu S, et al. Association of ADRB1 gene polymorphisms with pain sensitivity in a Chinese population. Int J Clin Exp Med. 2015;8:11514.
71. 10.12659/MSM.89406010.12659/MSM.894060 ↗